An investigation for investors in Marrone Bio Innovations Inc (NASDAQ:MBII) shares over potential securities laws violations by Marrone Bio Innovations was announced and NASDAQ:MBII stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com

San Diego, CA -- (SBWire) -- 09/08/2014 --An investigation on behalf of investors of Marrone Bio Innovations Inc (NASDAQ:MBII) shares over potential securities laws violations by Marrone Bio Innovations and certain of its directors and officers in connection certain financial statements was announced.

Investors who purchased shares of Marrone Bio Innovations Inc (NASDAQ:MBII) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Marrone Bio Innovations Inc (NASDAQ:MBII) concerning whether a series of statements by Marrone Bio Innovations regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Marrone Bio Innovations Inc reported that its annual Total Revenue rose from $7.14 million in 2012 to $14.54 million in 2013 and that its Net Loss declined from $38.79 million in 2012 to $28.49 million in 2013. Shares of Marrone Bio Innovations Inc (NASDAQ:MBII)

On September 3, 2014, Marrone Bio Innovations Inc announced that, at the recommendation of management, the Audit Committee of its Board of Directors has commenced an internal investigation after management learned of documents calling into question the recognition of revenue in the fourth quarter of 2013 for an $870,000 transaction. Marrone Bio Innovations Inc said its Audit Committee has retained independent legal advisers to assist it in this investigation. Additionally, the Audit Committee has determined that the company's financial statements for the fiscal year ended December 31, 2013, the unaudited interim financial statements for the three month period ended March 31, 2014 and the three- and six- month periods ended June 30, 2014, should no longer be relied upon as being in compliance with generally accepted accounting principles. Shares of Marrone Bio Innovations Inc (NASDAQ:MBII) declined from $18.65 per share in January 2014 to as $3.05 per share on September 4, 2014.

Those who purchased shares of Marrone Bio Innovations Inc (NASDAQ:MBII) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com